Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01915498
Title Phase 1/2 Study of Enasidenib (AG-221) in Adults With Advanced Hematologic Malignancies With an Isocitrate Dehydrogenase Isoform 2 (IDH2) Mutation
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Celgene
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | FRA

Facility Status City State Zip Country Details
City Of Hope Duarte California 91010-301 United States Details
Stanford Cancer Center Stanford California 94305 United States Details
University Of Colorado Cancer Center Aurora Colorado 80045 United States Details
University of Miami Sylvester Cancer Center Miami Florida 33136 United States Details
Florida Cancer Specialists Sarasota Florida 34232 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Northwestern University Chicago Illinois 60611-3008 United States Details
Massachusetts General Hospital Boston Massachusetts 02117 United States Details
Dana-Farber/Mass General Brigham Cancer Care, Inc Boston Massachusetts 02215 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Washington University Saint Louis Missouri 63110 United States Details
Cornell University Weill Medical College New York New York 10065 United States Details
Memorial Sloan-Kettering Cancer Center - NYC New York New York 10065 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
Ohio State University Gahanna Ohio 43230 United States Details
Oregon Health and Science University OHSU Portland Oregon 97239 United States Details
Sarah Cannon Research Institute Drug Development Unit Nashville Tennessee 37203 United States Details
Ut Southwestern Medical Center At Dallas Dallas Texas 75390-85520 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Local Institution - 202 Bordeaux 33076 France Details
Local Institution - 204 Paris 75010 France Details
Local Institution - 203 Pessac 33604 France Details
Local Institution - 205 Toulouse 31059 France Details
Local Institution - 201 Villejuif 94805 France Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field